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Lymphocytic hypophysitis
and central diabetes insipidus
during adolescence: what are
the criteria for diagnosis?
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Sir: We read with interest the paper of
Cemeroglu et al [1] describing a 14-year-old
girl with acute central diabetes insipidus
(DI), secondary amenorrhoea and normal
neurological and visual examinations. MRI
of the brain revealed a 10 ´ 10 ´ 10 mm
mass involving the pituitary stalk and
hypothalamus which spontaneously re-
duced within 3 months and returned to
10 ´ 8 ´ 10 mm 3 months later. At 6
months the T1-weighted posterior pituitary
hyperintensity was absent (no mention of
the posterior pituitary status on initial
MRI). Endocrine evaluation revealed
hypogonadotropic hypogonadism and low
insulin-like-growth-factor-I (IGF-I) level.
Histological examination showed signs of
chronic in¯ammation with a predominant
lymphocytic in®ltrate compatible with
lymphocytic hypophysitis.
We wish to make some comments and
suggestions:
We have described an 8-year-old girl
with acute onset central DI and acquired
growth hormone (GH) insuciency in
whom the ®rst MRI showed a thick pitu-
itary stalk and undetectable posterior pitu-
itary hyperintensity [2]. Serial MRI studies
were unchanged for 5 years when a huge
mass involving the pituitary stalk and
hypothalamus was documented togeher
with clinical and laboratory features of
panhypopituitarism. Histopathology re-
vealed perivascular in¯ammatory lympho-
plasmatic in®ltrates with absence of
granulomatosis and necrosis and negative
staining for S-100 protein. The patient was
treated with high dose prednisolone
(30 mg/kg per day, total dose of 2.4 g in
20 min infusion for 3 days). MRI per-
formed 1 month later showed an approxi-
mately 50% decrease in the mass, with
partial anterior pituitary recovery (thyroid
and adrenal) maintained for 2 years after
treatment began.
In our opinion, the features reported by
Cemeroglu et al. [1] do not permit a
convincing diagnosis of classical lympho-
cytic hypophysitis as traditionally con-
ceived: the disease onset is unrelated to
pregnancy, the posterior pituitary is in-
volved, the mass on coronal MRI is con-
®ned to the pituitary stalk and
hypothalamus while the anterior pituitary is
spared, there is no evidence of lymphocyte
in®ltration and/or destruction of the ante-
rior pituitary tissue and no other co-existing
auto-immune disorders are associated [3].
We believe that the disease reported by
Cemeroglu et al. [1] belong to a unique
spectrum of in¯ammatory auto-immune
vascular-mediated conditions variably af-
fecting the hypothalamic-pituitary area.
The statement that ``the loss of the normal
posterior pituitary T1-weighted hyperin-
tensity may have been a clue to the diag-
nosis of lymphocytic hypophysitis before
biopsy in this case'' is rather misleading
because the lack of posterior pituitary
hyperintensity in central DI is a non-
speci®c hallmark of a hypothalamic-neuro-
hypophyseal axis lesion [2, 4].
The conservative management of these
tumour-like conditions appears reasonable
but in the patient reported by Cemeroglu et
al., the chronic growth pattern and the size
of the mass as well as the documentation of
an in¯ammatory process after pituitary
stalk biopsy require in our opinion a
tentative treatment approach. Only few
controversial data with dierent treatment
modalities and outcome have been reported
but the favourable response to
glucocorticoids in our patient underlines
the possible role of steroids in the
management of such in¯ammatory masses.
We believe that the low IGF-I level and
patient weight increase (6.8 kg.) may have
been due to acquired GH insuciency
which is frequently associated with such
lesions. Thus, evaluation of GH secretion
and clinical indication for GH treatment
(metabolic and quality of life eects in
adults) in case of GH de®ciency merit
consideration.
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Sir:We are pleased to have the opportunity
to update our report on each of the issues
addressed in Dr. Maghnie's letter.
In the last few years, the broad spec-
trum of presentation of the condition
known as lymphocytic hypophysitis
(LYHY) has been established. Thus,
LYHY can aect men and women and
need not be related to pregnancy
[1, 4, 5, 9, 10]. LYHY is not only con®ned
to the anterior pituitary but can involve
the posterior pituitary and the stalk [2, 14].
The term LYHY is used globally to
describe a spectrum of pathology. Based
on anatomical site and severity of the
in¯ammatory process, LYHY can be sub-
classi®ed as lymphocytic hypophysitis,
lymphocytic infundibulo-neurohypophysi-
tis and necrotizing infundibulo-hypo-
physitis. We elected to use the global term
of LYHY in our report. We absolutely
agree that the imaging studies performed
in our patient point to pituitary stalk and
hypothalamic involvement. As stated by
Dr. Maghnie, this does not ®t the classical
diagnosis of lymphocytic hypophysitis
strictly de®ned by anatomical features but,
again, LYHY was used in the broader
sense which encompases the whole spec-
trum of this condition. Because of the age
of our patient, we did not originally
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consider LYHY in the dierential diag-
nosis and were surprised at the biopsy
results.
We agree that current diagnostic tech-
niques limit our ability to diagnose and
dierentiate LYHY from other processes
that may or may not be related to LYHY
(LYHY vs lymphocytic infundibulo-ne-
urohypophysitis vs necrotizing infundibulo-
hypophysitis). Serum antipituitary anti-
bodies, measured by an immuno¯uores-
cence technique using rodent pituitary cell
lines GH3 and AtT-20 may become useful
tools to con®rm the diagnosis of LYHY in
the future [4].
Treatment options are limited for
LYHY. Glucocorticoid treatment is indi-
cated in LYHY when increased intracra-
neal pressure is documented or suspected.
In the absence of signs of increased intra-
craneal pressure, clear bene®ts from gluco-
corticoid therapy are observed in only 50%
to 60% of cases [13]. Considering the
bene®t/risk ratio of a glucocorticoid trial,
this treatment option was declined by the
family.
Hormone supplementation is indicated
for treatment of speci®c hormone de®cien-
cies. As mentioned in our article, we
suspected growth hormone (GH) de®ciency
in our patient. However, at 14 years of age,
our patient had achieved most of her height
potential. GH supplementation in adults is
bene®cial particularly for maintenance of
lean body mass and muscle strength [6, 8].
However, the use of GH in adolescence is
still controversial. Even in adults, the eect
of GH treatment on mood, lipid pro®le and
bone density is disputed [3]. Detrimental
eects from GH include reduction of cir-
culating cortisol levels [12], increased left
ventricular wall thickness [7] and elevated
lipoprotein-a which is an independent risk
factor for cardiovascular disease [11]. Dose,
duration of GH treatment, long-term side-
eects, quality of life changes and economic
implications of the treatment remain to be
assessed. Only if they are ®rmly established
can we justify a lifelong, expensive injection
treatment.
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